High specificity of quantitative methylation-specific pcr analysis for mgmt promoter hypermethylation detection in gliomas

30Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Normal brain tissue from 28 individuals and 50 glioma samples were analyzed by real-time Quantitative Methylation-Specific PCR (QMSP). Data from this analysis were compared with results obtained on the same samples by MSP. QMSP analysis demonstrated a statistically significant difference in both methylation level (P =.000009 Mann Whitney Test) and frequencies (P =.0000007, Z-test) in tumour samples as compared with normal brain tissues. Although QMSP and MSP showed similar sensitivity, the specificity of QMSP analysis was significantly higher (93; CI95: 84-100) as compared with MSP (64; 95CI: 46-82). Our results suggest that QMSP analysis may represent a powerful tool to identify glioma patients that will benefit from alkylating agents chemotherapy. Copyright © 2009 Paola Parrella et al.

Cite

CITATION STYLE

APA

Parrella, P., La Torre, A., Copetti, M., Valori, V. M., Barbano, R., Notarangelo, A., … Fazio, V. M. (2009). High specificity of quantitative methylation-specific pcr analysis for mgmt promoter hypermethylation detection in gliomas. Journal of Biomedicine and Biotechnology, 2009. https://doi.org/10.1155/2009/531692

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free